Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-04-02 09:01 am Sale | 13D | NEON THERAPEUTICS INC NTGN | Access Industries Holdings LLC | 2,153,803 7.46% | -400,000 (-15.66%) | View |
| 2020-03-27 2:29 pm Sale | 13D | NEON THERAPEUTICS INC NTGN | Access Industries Holdings LLC | 2,553,803 8.85% | -544,110 (-17.56%) | View |
| 2020-03-23 08:16 am Purchase | 13G | NEON THERAPEUTICS INC NTGN | JFL Capital Management LP | 1,519,819 5.3% | 1,519,819 (New Position) | View |
| 2020-02-14 4:05 pm Sale | 13G | NEON THERAPEUTICS INC NTGN | PFM Health Sciences LP | 0 0% | -1,811,360 (Position Closed) | View |
| 2020-02-07 11:26 am Sale | 13G | NEON THERAPEUTICS INC NTGN | FMR LLC | 1,528,496 5.393% | -551,173 (-26.50%) | View |
| 2020-01-27 3:36 pm Sale | 13G | NEON THERAPEUTICS INC NTGN | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -2,234,756 (Position Closed) | View |
| 2020-01-23 4:01 pm Purchase | 13D | NEON THERAPEUTICS INC NTGN | BioNTech SE BNTX | 10,407,745 36.2% | 10,407,745 (New Position) | View |